Viewing Study NCT04058067


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-02-24 @ 8:25 AM
Study NCT ID: NCT04058067
Status: COMPLETED
Last Update Posted: 2024-10-09
First Post: 2019-08-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
Sponsor: Novartis Pharmaceuticals
Organization: